Benchmark analyst maintained a Hold rating on shares of Neogenomics (NASDAQ: NEO). The analysis comes ahead of the company's investor conference presentation scheduled for the same day. The company, ...

(NEO) stock saw a modest uptick, ending the day at $14.71 which represents a slight increase of $0.93 or 6.75% from the prior close of $13.78. The stock opened at $14.95 and touched a low of $14.48 ...

Uranium developer Neo Energy Metals has appointed investment and merchant banking boutique Bacchus Capital Advisers as its strategic and financial adviser. Bacchus Capital specialises in strategic and ...

Needham analyst Michael Matson reiterated a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00.Stay Ahead ...

NeoGenomics (NASDAQ:NEO) shares popped ~4% premarket on Wednesday after the oncology testing services company set a revenue ...

The company said, “The Long-Range Plan builds upon the successful execution of the previous three years. NeoGenomics (NEO) intends to achieve ...

The Magnus Neo represents the evolution of Ampere's Magnus EX and is set to deliver more style, more power, more strength, more safety, and more savings. The Magnus Neo will take center stage at Auto ...

Known for her commitment to championing Southeast Asian contemporary art, Singaporean art collector Linda Neo, together with ...

NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a note issued to investors on Friday,Benzinga reports. They ...

Stock analysts at Leerink Partnrs raised their FY2024 EPS estimates for shares of NeoGenomics in a report issued on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now anticipates that the ...

Neo Asset Management, founded in 2021 and backed by venture company Peak XV Partners as well as Japanese financial group MUFG ...

The UK Government has today (8th January 2025) announced a full asset freeze against Blood and Honour, an entity it has ...